Since 1971, NIAID has supported targeted research to understand the causes of and develop preventions and treatments for asthma, a respiratory disease that affects approximately 25 million Americans, including 7 million children aged 17 years and under. NIAID research focuses on understanding how the environment, allergens, and genetics interact with the body's immune system to cause the disease and aggravate the symptoms.
Statement on World Asthma Day 2016—May 3, 2016
Media Availability: Omalizumab Decreases Colds in Inner-City Children with Asthma, NIH Study Reports—March 5, 2016
Short-Term Additional Treatment Reduces Asthma Attacks in Inner-City Children During Fall—Oct. 27, 2015
Researchers Refine How Immune Pathways Contribute to Asthma—Aug. 19, 2015
All Asthma News Releases
News From NIAID-Supported Institutions
Last Updated May 03, 2016